Leukaemia vs Lymphoma: Understanding Blood Cancer Differences

What is the difference between leukaemia and lymphoma?

Leukaemia is a blood cancer that originates in the bone marrow and causes abnormal white blood cells to flood the bloodstream. Lymphoma is a blood cancer that begins in the lymphatic system — specifically in lymphocytes — and typically presents as swollen lymph nodes. Both are haematological cancers but differ in origin, behaviour, and treatment approach.

S.L. Raheja Hospital in Mumbai offers specialised haematology services for patients with both leukaemia and lymphoma, providing accurate diagnosis and evidence-based treatment planning.

How do leukaemia and lymphoma differ in origin, symptoms, and diagnosis?

While both conditions involve abnormal lymphocytes or white blood cells, their point of origin, clinical presentation, and diagnostic pathways are distinct. The table below summarises the key differences.

What are the early warning signs of leukaemia and lymphoma?

Symptoms of both cancers can overlap, which is why clinical evaluation and blood tests are essential for an accurate diagnosis. Recognising early signs improves outcomes significantly.

Early warning signs of leukaemia include:

• Persistent fatigue and weakness not explained by lifestyle
• Frequent or recurring infections
• Unexplained bruising or bleeding easily
• Pale skin or anaemia
• Bone or joint pain
• Swollen lymph nodes, liver, or spleen
• Unexplained weight loss

Early warning signs of lymphoma include:

• Painless swelling of lymph nodes in the neck, armpit, or groin
• Persistent fever without infection
• Drenching night sweats
• Unexplained weight loss of more than 10% body weight
• Itchy skin without rash
• Fatigue and breathlessness
• Abdominal swelling or discomfort

How is leukaemia or lymphoma diagnosed?

Diagnosis requires a combination of laboratory investigations and imaging. A haematologist will guide the appropriate pathway based on the patient's presentation.

Common diagnostic steps include:

1. Complete Blood Count (CBC): Identifies abnormal white blood cell levels — often the first indicator of leukaemia.
2. Peripheral blood smear: Examines the shape and type of blood cells under a microscope.
3. Bone marrow biopsy: A small sample of bone marrow is taken (usually from the hip bone) to confirm leukaemia type and extent.
4. Lymph node biopsy: A tissue sample from a swollen lymph node is examined to confirm lymphoma and determine its subtype.
5. Imaging (PET/CT scan): Used primarily in lymphoma staging to identify affected lymph nodes and organs.
6. Flow cytometry and immunophenotyping: Classifies the specific cancer cell type to guide targeted treatment.

At S.L. Raheja Hospital, Mumbai, the haematology team coordinates these investigations to arrive at a precise diagnosis and personalised treatment plan.

How are leukaemia and lymphoma treated, and which is more treatable?

Both leukaemia and lymphoma are treatable, and many subtypes — particularly Hodgkin lymphoma and certain forms of acute leukaemia — have high response rates to therapy. Treatability depends on the specific subtype, stage, and the patient's overall health.

Treatment options for leukaemia:

• Chemotherapy (the primary treatment for most leukaemia types)
• Targeted therapy (e.g. tyrosine kinase inhibitors for CML)
• Immunotherapy
• Bone marrow transplant — used in high-risk or relapsed cases to replace diseased marrow with healthy stem cells
• Radiation therapy (less common, used for specific sites)

Treatment options for lymphoma:

• Chemotherapy (standard for most lymphoma types)
• Immunotherapy (e.g. monoclonal antibodies such as rituximab for B-cell lymphomas)
• Radiation therapy (particularly for early-stage Hodgkin lymphoma)
• Stem cell transplant for relapsed or refractory disease
• CAR-T cell therapy in eligible cases

Hodgkin lymphoma is generally considered highly responsive to treatment. Among leukaemias, chronic forms such as CML are well-controlled with targeted oral therapy. Acute forms require more intensive treatment but can achieve remission.

When should you see a haematologist for blood cancer symptoms?

Many symptoms of leukaemia and lymphoma are non-specific and can mimic common illnesses. However, certain patterns warrant urgent specialist evaluation.

Seek a haematology consultation if you experience:

• Swollen, painless lymph nodes persisting for more than 2 weeks
• Unexplained fever lasting more than 3 weeks
• Night sweats severe enough to soak clothing, occurring on most nights
• Unexplained weight loss of more than 5–10% of body weight over 6 months
• Fatigue that does not improve with rest and has no clear cause
• Repeated infections or slow wound healing
• Unexplained bruising or bleeding, including nosebleeds or bleeding gums
• Bone pain, particularly in the back, hips, or ribs

A general physician may order an initial blood count, but a haematologist is best placed to interpret abnormal results and arrange further investigations such as a bone marrow biopsy or lymph node biopsy.

How does S.L. Raheja Hospital in Mumbai support patients with blood cancers?

S.L. Raheja Hospital in Mumbai — located at Mahim West — provides dedicated haematology and oncology services for patients with leukaemia, lymphoma, and related blood disorders. The hospital's multidisciplinary team coordinates diagnosis, staging, and treatment planning across haematology, surgical oncology, and medical oncology.

Patients requiring advanced intervention have access to bone marrow transplant services, supported by a structured care pathway from pre-transplant evaluation through to post-transplant follow-up. The team works collaboratively to ensure each patient receives a treatment plan aligned with current clinical evidence.

To discuss symptoms or request a haematology consultation, use the booking form on this page or contact the hospital directly at info@rahejahospital.com.